New Amsterdam Pharma
Jim Luke, MBA has over 25 years of work experience in the finance industry. Jim began their career in 1997 as Director of Customer Financial Planning & Analysis at Warner Lambert. In 2001, they moved to Reliant Pharmaceuticals as Sr. Manager of R & D Finance. Jim then joined Pfizer Consumer Healthcare in 2007 as Sr. Manager of Sales Finance. In 2012, they were appointed Director of Corporate Financial Planning & Analysis at Aphena Pharma Solutions, Inc. In 2013, they were promoted to Director of Sales Finance at Pinnacle Foods Group LLC. Jim then joined The Hain Celestial Group in 2017 as Director of Customer Finance, and is currently a R & D Finance Liaison at NewAmsterdam Pharma since 2022.
Jim Luke holds a Bachelor of Science in Accounting from the University of Scranton and a Master of Business Administration in Finance from Fairleigh Dickinson University-Florham Campus.
This person is not in any offices
New Amsterdam Pharma
1 followers
Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.